Summary

Molecular Farming Market Size
The global molecular farming market size was valued at $526.76 million in 2024 and is projected to reach $1,283.39 million by 2030, growing at a CAGR of 16.0% during the forecast period.

Molecular Farming Market Overview
Molecular farming is a biotechnology technique that involves using genetically modified plants or animals to produce pharmaceutical substances, such as vaccines, antibodies, and therapeutic proteins. By inserting specific genes into the DNA of these organisms, scientists can harness their natural biological processes to synthesize large quantities of valuable compounds. This method offers a cost-effective and scalable alternative to traditional production methods, which often rely on cell cultures or chemical synthesis. Molecular farming can also improve the safety and accessibility of pharmaceuticals by leveraging the established agricultural infrastructure for cultivation and harvesting.

Molecular Farming Market Dynamics
• The molecular farming market is expected to witness significant growth in the future due to increasing demand for cost-effective biopharmaceuticals, advances in genetic engineering and biotechnology, and growing prevalence of chronic diseases.
• Additionally, rising investment in research and development and the supportive government policies and funding initiatives are the prominent factors driving the growth of the market.
• However, the high initial costs, technical complexities, and stringent approval processes are restraining the market growth.
• On the contrary, the development of new plant-based vaccine platforms and advancements in precision farming are creating opportunities for market growth.

By Type, the Plant Segment Constitutes Immense Share with Molecular Farming Market
The plant segment holds a significant share within the molecular farming market. Plants offer a scalable, cost-effective, and environmentally friendly platform for producing high-value pharmaceutical compounds. Unlike traditional methods that rely on microbial fermentation or mammalian cell cultures, plant-based systems can be cultivated in large quantities using existing agricultural infrastructure, significantly reducing production costs. Additionally, plants can be genetically engineered to produce complex proteins and other biologically active molecules that are difficult to synthesize through conventional means. This makes them an attractive option for developing vaccines, antibodies, and therapeutic proteins. The relative ease of scaling up plant-based production and the potential for rapid response to emerging health threats further bolster the demand for molecular farming in the plant segment. Moreover, advances in genetic engineering and plant biotechnology continue to enhance the efficiency and yield of these systems, making them increasingly viable and appealing for pharmaceutical applications.

By Geography, Asia Pacific is Projected to Show Strong Presence in the Molecular Farming Market
Asia Pacific is anticipated to show a robust presence during the forecast period due to the region's large and growing population, coupled with an increasing prevalence of chronic diseases. Molecular farming offers a cost-effective alternative to traditional pharmaceutical production methods, aligning well with the economic constraints of many countries in the region. Additionally, the Asia Pacific region is witnessing rapid advancements in biotechnology and agricultural sciences, supported by substantial government investments and favorable policies. The presence of a robust agricultural sector provides a solid foundation for large-scale plant-based production systems. Furthermore, the rising middle-class population in countries like China and India is increasing demand for innovative and high-quality biopharmaceutical products. The region's strategic focus on improving healthcare infrastructure and expanding access to cutting-edge medical technologies further fuels the growth of the molecular farming market in the Asia Pacific.

Key Target Audience:
• Pharmaceutical Companies
• Biotechnology Firms
• Agricultural Businesses
• Research and Academic Institutions
• Government and Regulatory Agencies
• Investors and Venture Capitalists
• Healthcare Providers and Medical Professionals

List of the Key Players Profiled in the Report Includes:
• Avaxin Biologics
• Bright Biotech
• LFB Biotechnologies SA
• Mapp Biopharmaceutical
• Medicargo
• Miruku
• Mozza
• Nobell Foods
• ORF Genetics
• Pfizer
• Pharming Group NV
• Tiamat Sciences

Recent Developments:
• In May 2024, Bright Biotech installed its first Lab-Model S for molecular farming protein production. This innovative fogponic technology, now operational in Manchester laboratory, aims to enhance plant biomass yield and quality while reducing energy and water consumption.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Type:
• Plant
• Animal

Market by, Application:
• Medical Treatment
• Food
• Pesticide
• Other Applications

Market by, End User:
• Nutraceutical
• Pharmaceutical
• Dairy
• Other End Users

Market by, Geography:
The molecular farming market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

Scope of the Report:
The report “Global Molecular Farming Market: Industry Analysis, Opportunities and Forecast up to 2030” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2022, 2023 and offers revenue estimations for 2024, and project forecasts spanning from 2025 to 2030. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Molecular Farming Market by, Type
6.1 Overview
6.2 Plant
6.3 Animal

7 Global Molecular Farming Market by, Application
7.1 Overview
7.2 Medical Treatment
7.3 Food
7.4 Pesticide
7.5 Other Applications

8 Global Molecular Farming Market by, End User
8.1 Overview
8.2 Nutraceutical
8.3 Pharmaceutical
8.4 Dairy
8.5 Other End Users

9 Global Molecular Farming Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa

10 Key Developments

11 Company Profiling
11.1 Avaxin Biologics
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 Bright Biotech
11.3 LFB Biotechnologies SA
11.4 Mapp Biopharmaceutical
11.5 Medicargo
11.6 Miruku
11.7 Mozza
11.8 Nobell Foods
11.9 ORF Genetics
11.10 Pfizer
11.11 Pharming Group NV
11.12 Tiamat Sciences